Two layer compression bandage system + contact layer with TLC-NOSF Technology

Composition and properties

 UrgoKTwo® with UrgoStart is the unique synergy of two innovative technologies promoting excellence in the treatment of venous leg ulcers. It combines UrgoKTwo® (two layer compression bandage system) and UrgoStart® Contact (contact layer with TLC-NOSF Technology) to promote faster healing.

 

Properties:

  • UrgoStart® Contact
    • Reduce time to healing and improves patient’s quality of life (1,2)
    • With all the benefits of TLC: pain-free dressing changes (2,3,4,5), moist wound-healing (3,6), good tolerance (1,2), stimulation of fibroblast proliferation (7,8)
    • Clinically proven in a Randomised Controlled Trial with Venous Leg Ulcers: 54.4% reduction in wound surface area after 12 weeks treatment (2)
  • UrgoKTwo®
    • Safe and effective compression therapy  (9,10,11)
    • Effective reduction of oedema in Venous Leg Ulcer management (12)
    • Quick and easy to apply (10,12)
    • Excellent patient concordance (10,12)
    • Very high levels of patient comfort (12)
    • Allows patients to wear regular shoes (12)
    • Improves quality of life (12)
    • Clinically proven (10,12)

 

Indications

  • Treatment of Venous Leg Ulcers
  • Minimum duration of treatment 4-5 weeks

 

Method of use

  • Can be left in place for up to 7 days

 

Sizes available

 

Size PIP Code
Kits
18 - 25 cm 344-5319
25 - 32 cm 344-5327

 

Reference:

(1) Meaume S. et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-Oligo Saccharide Factor wound dressing in the local management of venous leg ulcers. ; Wound Rep Reg. 2012 (July/ August) vol 20 issue 4, p 500-511

(2) Schmutz JL. et al. Evaluation of the nano-oligo saccharide factor lipido-colloid matrix in the local management of venous leg ulcers: Results of a randomised controlled trial. International Wound Journal 2008; 5 (2):172-82.

(3) Benbow M., Iossen G. A clinical evaluation of UrgoTul to treat acute and chronic wounds. Br J Nurs 2004: 13 (2): 105-109.

(4)  Meaume S. et al. Optimizing wound care with a new lipido-colloid dressing (UrgoTul Duo) Br J Nurs 2007: 16 (6): S4-12.

(5) Fays S. et al. Leg ulcers and the UrgoCell Non-Adhesive wound dressing. Br J Nurs 2005: 14 (11):S15-20.

(6) Winter G.D. Formation of the scab and rate of epithelialisation of superficial wounds in the skin of the young domestic pig. Nature 1962; 193: 293-294.

(7) Bernard F.X. et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipido-colloid dressing J Wound Care 2005; 14 (5): 215-220.

(8) UrgoStart®, UrgoStart® Contact. Data on file. 2011. Urgo.

(9) Junger M. et al. Comparison of interface pressure of three different bandaging systems used on healthy volunteers: Results of a
prospective randomized clinical study. J Wound Care 2009; 18(20):474-480.

(10) Hanna R. et al. A comparison of interfaces pressures of three compression bandages systems. Br J Nursing 2008; 17(20).

(11) Thompson A. Stenton E. Leg Ulcer Management: A cost effectiveness study JCN Nov / Dec 2010 vol 24 (6)

(12)  Schmutz JL. et al. Evaluation of the nano-oligo saccharide factor lipido-colloid matrix in the local management of venous leg
ulcers: Results of a randomised controlled trial. International Wound Journal 2008; 5 (2):172-82.